BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12203739)

  • 1. Developmental expression of alpha4 protein phosphatase regulatory subunit in tissues affected by Opitz syndrome.
    Everett AD; Brautigan DL
    Dev Dyn; 2002 Aug; 224(4):461-4. PubMed ID: 12203739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MID1 and MID2 homo- and heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, alpha 4, to microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disorders.
    Short KM; Hopwood B; Yi Z; Cox TC
    BMC Cell Biol; 2002; 3():1. PubMed ID: 11806752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit alpha 4.
    Liu J; Prickett TD; Elliott E; Meroni G; Brautigan DL
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6650-5. PubMed ID: 11371618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mig12, a novel Opitz syndrome gene product partner, is expressed in the embryonic ventral midline and co-operates with Mid1 to bundle and stabilize microtubules.
    Berti C; Fontanella B; Ferrentino R; Meroni G
    BMC Cell Biol; 2004 Feb; 5():9. PubMed ID: 15070402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation.
    Trockenbacher A; Suckow V; Foerster J; Winter J; Krauss S; Ropers HH; Schneider R; Schweiger S
    Nat Genet; 2001 Nov; 29(3):287-94. PubMed ID: 11685209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MID1/PP2A complex: a key to the pathogenesis of Opitz BBB/G syndrome.
    Schweiger S; Schneider R
    Bioessays; 2003 Apr; 25(4):356-66. PubMed ID: 12655643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MID2, a homologue of the Opitz syndrome gene MID1: similarities in subcellular localization and differences in expression during development.
    Buchner G; Montini E; Andolfi G; Quaderi N; Cainarca S; Messali S; Bassi MT; Ballabio A; Meroni G; Franco B
    Hum Mol Genet; 1999 Aug; 8(8):1397-407. PubMed ID: 10400986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Widely spaced alternative promoters, conserved between human and rodent, control expression of the Opitz syndrome gene MID1.
    Landry JR; Mager DL
    Genomics; 2002 Nov; 80(5):499-508. PubMed ID: 12408967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duplication of the MID1 first exon in a patient with Opitz G/BBB syndrome.
    Winter J; Lehmann T; Suckow V; Kijas Z; Kulozik A; Kalscheuer V; Hamel B; Devriendt K; Opitz J; Lenzner S; Ropers HH; Schweiger S
    Hum Genet; 2003 Mar; 112(3):249-54. PubMed ID: 12545276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FXY2/MID2, a gene related to the X-linked Opitz syndrome gene FXY/MID1, maps to Xq22 and encodes a FNIII domain-containing protein that associates with microtubules.
    Perry J; Short KM; Romer JT; Swift S; Cox TC; Ashworth A
    Genomics; 1999 Dec; 62(3):385-94. PubMed ID: 10644436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MID1 catalyzes the ubiquitination of protein phosphatase 2A and mutations within its Bbox1 domain disrupt polyubiquitination of alpha4 but not of PP2Ac.
    Du H; Wu K; Didoronkute A; Levy MV; Todi N; Shchelokova A; Massiah MA
    PLoS One; 2014; 9(9):e107428. PubMed ID: 25207814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active transport of the ubiquitin ligase MID1 along the microtubules is regulated by protein phosphatase 2A.
    Aranda-Orgillés B; Aigner J; Kunath M; Lurz R; Schneider R; Schweiger S
    PLoS One; 2008; 3(10):e3507. PubMed ID: 18949047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterisation of the chick orthologue of the Opitz syndrome gene, Mid1, supports a conserved role in vertebrate development.
    Richman JM; Fu KK; Cox LL; Sibbons JP; Cox TC
    Int J Dev Biol; 2002; 46(4):441-8. PubMed ID: 12141430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A structure-function study of MID1 mutations associated with a mild Opitz phenotype.
    Mnayer L; Khuri S; Merheby HA; Meroni G; Elsas LJ
    Mol Genet Metab; 2006 Mar; 87(3):198-203. PubMed ID: 16378742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional observations of the P151L MID1 mutation reveal alpha4 plays a significant role in X-linked Opitz Syndrome.
    Wright KM; Du H; Massiah MA
    FEBS J; 2017 Jul; 284(14):2183-2193. PubMed ID: 28548391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Opitz syndrome gene product, MID1, associates with microtubules.
    Schweiger S; Foerster J; Lehmann T; Suckow V; Muller YA; Walter G; Davies T; Porter H; van Bokhoven H; Lunt PW; Traub P; Ropers HH
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2794-9. PubMed ID: 10077590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild phenotypes in a series of patients with Opitz GBBB syndrome with MID1 mutations.
    So J; Suckow V; Kijas Z; Kalscheuer V; Moser B; Winter J; Baars M; Firth H; Lunt P; Hamel B; Meinecke P; Moraine C; Odent S; Schinzel A; van der Smagt JJ; Devriendt K; Albrecht B; Gillessen-Kaesbach G; van der Burgt I; Petrij F; Faivre L; McGaughran J; McKenzie F; Opitz JM; Cox T; Schweiger S
    Am J Med Genet A; 2005 Jan; 132A(1):1-7. PubMed ID: 15558842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative polyadenylation signals and promoters act in concert to control tissue-specific expression of the Opitz Syndrome gene MID1.
    Winter J; Kunath M; Roepcke S; Krause S; Schneider R; Schweiger S
    BMC Mol Biol; 2007 Nov; 8():105. PubMed ID: 18005432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of midline defect-causing mutation P151L in MID1 revealed.
    Nicholson LK
    FEBS J; 2017 Jul; 284(14):2167-2169. PubMed ID: 28714291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical and microarray analyses of a mouse model for the smith-lemli-opitz syndrome.
    Waage-Baudet H; Dunty WC; Dehart DB; Hiller S; Sulik KK
    Dev Neurosci; 2005; 27(6):378-96. PubMed ID: 16280635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.